Clinical Trial Update: KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating intra-tumoural hydrogen peroxide (KORTUC) as a radiation sensitizer in locally advanced or recurrent breast cancer, assessing toxic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KORTUC

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED